Screener
Charles River Laboratories CRL Acquisitions
Acquisitions at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Other assets and liabilities, net | (20,335) | (22,208) |
| Net cash provided by operating activities | 220,802 | 376,300 |
| Cash flows relating to investing activities | ||
| Acquisition of businesses and assets, net of cash acquired | (467,254) | — |
| Capital expenditures | (87,013) | (94,622) |
| Purchases of investments and contributions to venture capital investments | (11,805) | (8,090) |
| Proceeds from sale of investments | 11,059 | 2,106 |
| Proceeds from sale of businesses and assets, net | 176,563 | 17,441 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's acquisitions?
- Charles River Laboratories (CRL) reported acquisitions of $62.25M in Q2 2026.
- What does acquisitions mean?
- Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.
Ask your AI about Charles River Laboratories's acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude